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Abstract
Background: Since normal brain function depends upon continuous oxygen delivery and short periods of hypoxia
can precondition the brain against subsequent ischemia, this study examined the effects of brief hypoxia on the
whole genome transcriptional response in adult mouse brain.
Result: Pronounced changes of gene expression occurred after 3 hours of hypoxia (8% O2) and after 1 hour of
re-oxygenation in all brain regions. The hypoxia-responsive genes were predominantly up-regulated in hindbrain
and predominantly down-regulated in forebrain - possibly to support hindbrain survival functions at the
expense of forebrain cognitive functions. The up-regulated genes had a significant role in cell survival and
involved both shared and unshared signaling pathways among different brain regions. Up-regulation of
transcriptional signaling including hypoxia inducible factor, insulin growth factor (IGF), the vitamin D3 receptor/
retinoid X nuclear receptor, and glucocorticoid signaling was common to many brain regions. However, many
of the hypoxia-regulated target genes were specific for one or a few brain regions. Cerebellum, for example,
had 1241 transcripts regulated by hypoxia only in cerebellum but not in hippocampus; and, 642 (54%) had at
least one hepatic nuclear receptor 4A (HNF4A) binding site and 381 had at least two HNF4A binding sites in
their promoters. The data point to HNF4A as a major hypoxia-responsive transcription factor in cerebellum in
addition to its known role in regulating erythropoietin transcription. The genes unique to hindbrain may play
critical roles in survival during hypoxia.
Conclusion: Differences of forebrain and hindbrain hypoxia-responsive genes may relate to suppression of
forebrain cognitive functions and activation of hindbrain survival functions, which may coordinately mediate the
neuroprotection afforded by hypoxia preconditioning.
Background
Given that brain depends upon rapid and continuous
delivery of oxygen to maintain normal function and sur-
vival, it may have developed unique molecular responses
to hypoxia as compared to other organs and organisms.
In spite of the crucial role of oxygen in normal brain
function, there have been relatively few studies of brain
hypoxia at the whole genome level. Previous studies
using early-generation microarrays found changes of
expression in whole brain of neonatal rat (34 genes up-
regulated, 42 genes down regulated) and in cerebral cor-
tex of adult mice (29 genes up regulated) [1,2]. Thus,
this study was undertaken in part to examine the brain
hypoxia response at the whole genome level in vivo.
One of the major goals of this study, however, was to
define the regional, whole genome changes of gene
expression that could account for the phenomenon of
“hypoxia preconditioning” (HP)[3-7]. In the first
described brain HP model, exposure of neonatal rats
to 3 hours of 8% oxygen almost completely protected
against hypoxia-ischemia induced infarction [3]. In
adult mouse brain, hypoxia preconditioning 24 to 48
hours in advance can reduce infarct volume up to 64%
[6,8]. Moreover, the protection provided by HP can
last 5-8 weeks [9,10]. Thus, HP may offer an important
platform for the discovery of neuroprotective targets.
Though extensively studied, the precise mechanisms
accounting for HP remain unknown. Since HP requires
new RNA and protein synthesis, we set out to study
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the adult C57BL/6 mouse brain using Affymetrix
Expression Arrays (> 39,000 transcripts) [7,11,12]. The
dynamic gene expression changes were assessed over
the following 24 hours after HP- a time by which the
brain would be protected against focal ischemia [7].
Moreover, the expression changes were assessed on a
region by region basis: the regional differences of the
brain regarding its expression response to hypoxia/HP
have not been studied systemically. It is known that
certain brain regions and cells, such as hippocampal
pyramidal neurons, striatal medium spiny neurons and
cerebellar Purkinje neurons, are quite vulnerable to
hypoxia/ischemia whereas others can be relatively
resistant[13,14]. It is still not clear whether hypoxia/
HP responses could have predominantly engaged com-
mon or different mechanisms in different regions. One
previous study, using a neonatal rat hypoxia-precondi-
tioning model, showed differential molecular responses
in neocortex, hippocampus, striatum and thalamus,
even though HP produced similar protection in these
regions [15]. Thus, our current study further examined
the regional response to HP systemically at the geno-
mic level to determine whether there were common as
well as region-specific responses to hypoxia (8% O2)i n
the brain.
Our study examined both time- and region-dependent
transcriptional responses induced by HP in the adult
mouse brain. Besides hypoxia inducible factor (HIF),
various nuclear receptor transcription factors have been
found to play important roles in regulating both the
region-independent and region-specific gene expression
responses to HP. Different brain region exhibited differ-
ential but coordinated responses: in the forebrain, down
regulation of gene expression was predominant during
peak response period while the hindbrain, especially the
cerebellum, demonstrated predominant up-regulation
responses to HP. Surprisingly, the cerebellum demon-
strated the most profound gene expression response
among all regions and may play a pivotal role in the
protective effect of HP in vivo.
Results
Many hypoxia regulated gene products are in the nucleus
A one-way ANOVA, corrected for multiple comparisons
using a False Discovery Rate of 5%, yielded 2,324 tran-
scripts that changed 1.5 fold or more in at least one
brain region after HP treatment in adult C57BL/6 mice.
Many (~40%) of these 8% O2 hypoxia-regulated genes
have unknown functions. For the well annotated
hypoxia-regulated transcripts, almost half of the gene
products are located in the nucleus (48.2%) (Additional
file 1 figure S1A). Of these, many were transcriptional
regulators (34%) (Additional file 1 figure S1B).
Hypoxia-inducible transcription factor (HIF)
Of the 70 verified HIF-1a target genes [16], 17 changed
expression in brain following hypoxia (Additional file 2
t a b l eS 1 ) .F i v eo ft h e s eg e n e s –Adm, Cdkn1a, Ddit4,
Ets1, and Vegfa–had a similar time course of expression
changes in all brain regions, although the magnitudes of
their expression were not the same across different
regions (Figure 1A, Additional file 1 figure S2). The
other 12 HIF-1a target genes were differentially regu-
lated in different brain regions (Additional file 2 table
S1). Though there were more than 2,000 genes regu-
lated following hypoxia, only 92 changed expression in
all of the brain regions. Notably, 48% of these 92 genes
(38 genes) were identified as potential HIF target genes
by promoter analysis using the Genomatix Gene2pro-
moter analysis tool (Additional file 2 table S2).
Time course of gene expression regulation
The total numbers of genes that had increased or
decreased expression at each time point were summed
for the entire brain (Figure 1B). The greatest numbers
of regulated genes occurred immediately after the 3
hours of hypoxia and at one hour after re-oxygenation.
Thereafter, the number of regulated genes decreased
over time, with only a few regulated at 24 hours after
the hypoxia exposure (Figure 1B). This evolving pattern
of gene expression regulation over time also held true
for each individual brain region (Figure 2). For a given
brain region there were many more genes regulated at 3
hours of hypoxia compared to 1 hour of hypoxia, and
many different genes regulated at 1 hour of re-oxygena-
tion compared to 3 hours of hypoxia (Figure 1C). Thus,
there were relatively few genes that were commonly
regulated at two or more time points in a given brain
region (Figure 1C).
Region-dependent gene expression changes
As noted above, only 92 of the 2,324 transcripts regu-
lated by hypoxia were regulated in all of the brain
regions investigated. Thus, the hypoxia-regulated genes
differed between brain regions (Figure 2, venn diagram)
as did the total number of regulated genes. The pons
and medulla had the fewest number of regulated genes
(330 transcripts with a 1.5-fold threshold) and cerebel-
l u mh a dt h em o s t( 1 3 1 2t r a n s c r i p t sw i t ha1 . 5 - f o l d
threshold) (Figure 2). For each region there were up-
and down-regulated genes though down regulated genes
were more numerous in the forebrain (Figure 2, cortex,
hippocampus, striatum, and thalamus) whereas up-regu-
lated genes predominated in the midbrain, medulla/
pons, and particularly, cerebellum (Figure 2). However,
the total numbers of up- and down-regulated genes in
the brain as a whole are fairly comparable to each other
at each time point (Figure 1B).
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Page 2 of 16Figure 1 Time dependent gene expression changes induced by hypoxia. (A) Time course of expression of selected HIF-1 alpha target
genes in all brain regions studied derived from the microarray experiments. Adm: Adrenomedullin. Vegfa: Vascular endothelial growth factor A.
The y-axis is the expression value (normalized to the sham controls and log-transformed). The x-axis shows the time course of gene expression
in the following order: C, control; H1, 1 hour of hypoxia; H3, 3 hours of hypoxia; R1, 1 hour after reoxygenation; R3, 3 hours after reoxygenation;
R6, 6 hours after reoxygenation; R12, 12 hours after reoxygenation; R24, 24 hours after reoxygenation. Regions: cerebral cortex (Cortex),
hippocampus (Hippo.), striatum (Stri.), thalamus (Thal.), midbrain (Mid.), pons and medulla (Pon.), cerebellum (Cere.). (B). Total number of up-
regulated transcripts and total number of down-regulated transcripts in the entire brain. The y-axis is the number of up-regulated transcripts (red
line) or down-regulated transcripts (blue line) summed across all brain regions at each time point. The x-axis shows the time courses following
hypoxia. (C). Venn diagram of time-dependent gene expression changes in cerebral cortex from H1 through R1. These genes were derived by
performing a one-way ANOVA with a False Discovery Rate of 5% and with a fold change of ≥ 1.5 or greater.
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Page 3 of 16Gene expression changes in the forebrain related to cell
survival
There were generally many more down-regulated genes
than up-regulated genes in forebrain regions, a finding
similar to that reported for ischemic-preconditioning
[17]. A given gene was usually either down- or up-regu-
lated during the entire time course with very few excep-
tions: only 3 out of 503 genes in the cortex, 12 out 647
genes in the hippocampus, and 8 out 704 genes in the
striatum showed expression changes in both directions
during the 24 hour period. This means that hypoxia-
regulated genes can be simply divided into two classes:
up-regulated or down-regulated.
We then compared the overall molecular functions
of the up- and down-regulated genes in the forebrain
using the Ingenuity Knowledge Database. To minimize
the potential bias caused by an arbitrary fold change
filter, a minimum threshold of 1.2-fold was used for all
pathway analyses. Within each forebrain region, genes
involved in regulation of overall organismal survival
and development, cell death and survival, and cellular
growth and proliferation were significantly over-repre-
sented in the up-regulated genes compared to the
down-regulated genes (Figure 3). Similar findings were
obtained for all three forebrain regions even when dif-
ferent fold change thresholds were used. This result
was further confirmed by interaction network analysis,
which was used to construct the most prominent clus-
ters of genes in each of the forebrain regions based on
known molecular interactions in the literature. The top
networks of genes formed by the up-regulated genes
were associated with cell death/survival and prolifera-
tion in each of the forebrain regions (Additional file 2
table S3).
Figure 2 Regional differences in expression responses to hypoxia. Total number of up-regulated transcripts (red line, y-axis) was compared
to the number of down-regulated transcripts (blue line, y-axis) in each brain region as a function of time (x-axis). Insert: Venn diagram of
numbers of hypoxia-regulated transcripts in cerebral cortex (Cortex), hippocampus (Hippo.), and cerebellum during the whole time course
investigated using a one way ANOVA, FDR < 0.05 and fold change > 1.5.
Xu et al. BMC Genomics 2011, 12:499
http://www.biomedcentral.com/1471-2164/12/499
Page 4 of 16Since cerebral cortex, hippocampus and striatum
appear to respond similarly to hypoxia in terms of pre-
dominance of a decrease of gene expression, we
searched for common signaling pathways among them.
Using a 1.2-fold threshold, 314 transcripts were found
to be regulated in all three regions in the forebrain. A
two-way ANOVA analysis (regions and time courses
without FDR correction, p<0.05) on these 314 genes
further excluded 14 genes which showed region-depen-
dent expression changes among the forebrain regions.
This left 300 HP-regulated transcripts that had a consis-
tent temporal pattern of expression changes across cor-
tex, hippocampus and striatum. This was confirmed
using an unsupervised cluster analysis: the expression
profiles at the same time points from different regions
were similar to one another and therefore clustered
together compared to those from neighboring time
points (Additional file 1 figure S3).
Since the up-regulated genes in the forebrain had
more significant roles in regulating cell survival than
down-regulated genes (Figure 3), we focused our signal
pathway analysis on the common up-regulated genes
only (87 out of the 314 transcripts, the top cluster of
genes shown in Additional file 1 figure S3 and table S4).
Many signaling pathways were activated in response to
the hypoxia, and no single pathway or molecule can
account for the entire observed changes (Table 1). The
complexity of the gene/pathway responses following
hypoxia is demonstrated by the interaction network
formed by selected genes from the 87 up-regulated tran-
scripts (Additional file 1 figure S4).
The above pathway analyses suggested that a number
of transcription regulators likely play important roles in
up-regulating gene expression responses to hypoxia,
including HIF, glucocorticoid receptors and insulin like
growth factor (Table 1). To directly address which tran-
scription factors might be the most important, we per-
formed promoter analysis for the genes that were
induced after just 1 hour of hypoxia-This time point
was chosen because 1 h of preconditioning hypoxia is
sufficient to produce a protective effect comparable to
that induced by 3 hr or 6 hr of preconditioning hypoxia
[8]. Among the 87 up-regulated transcripts showing
consistent time courses of expression across the three
forebrain regions, 37 of these transcripts were up-regu-
lated early at one hour of hypoxia. Promoter analyses on
Figure 3 Molecular functions associated with up-regulated
genes and with down-regulated genes within each forebrain
region. The x-axis shows the categories of molecular functions
related to cell death/survival. The individual forebrain regions are
marked below the x-axis with colored squares: red, cerebral cortex;
blue, hippocampus; purple, striatum. The y-axis is the absolute value
of the log transformed P value, which means that a smaller P value
has a larger positive value on the y-axis. The value 1.3 on the y-axis
is equivalent to a P value of 0.05. The log transformed P value for
the functions associated with up-regulated genes is colored dark
red, while the value for down-regulated genes is colored light blue.
Dev.: Development; Org.: Organism; Repli.: Replication.
Table 1 Signaling pathways significantly associated with commonly up-regulated genes in all the forebrain regions
after HP.
Level Signal Classification Pathway P value Molecules*
System level Hormone Glucocorticoid Receptor Signaling 0.006 NFKBIA, FKBP5, CDKN1A, TSC22D3, SGK1
Hypoxia signaling Hypoxia signaling (Cardiovascular System) 0.016 NFKBIA, VEGFA
Tissue level Synapses Clathrin-mediated Endocytosis 0.076 VEGFA, AP2A2
Development Axonal Guidance/Ephrin Receptor Signal 0.093 VEGFA, GNA13
Cell level Growth factors Insulin/IGF-1 Receptor Signaling 0.054 PPP1R3C, SGK1, CYR61
Neuregulin/EGF Signaling 0.028 ERRFI1, TMEFF2
Survival regulation VDR/RXR Activation 0.023 KLF4, CDKN1A
p53 Signaling 0.026 CDKN1A, TP53INP1
Kinase cascade PI3K/AKT Signaling 0.046 NFKBIA, CDKN1A
ERK/MAPK Signaling 0.016 H3F3B, PPP1R3C, H3F3A
The significance was determined by Fisher’s exact test(P<0.1). Pathways with the same gene hits or with closely related genes were combined. The significance
of the combined pathway was determined by the smallest P value available before the combining.* Details of the genes can be found in Additional file 2 Table
S2.
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Page 5 of 16these genes (Genomatix Software) identified fourteen
transcription factor families that could have initiated
expression changes of these genes (Table 2). Transcrip-
tion factor families V$GREF (Glucocorticoid Responsive
and related Elements) and V$HIFF (HIF) were once
again present in the list, which is consistent with the
above pathways analysis (Table 1). Moreover, the gene
for one of the candidate transcription factors, Klf4,w a s
itself up-regulated at 1 hr after the onset of precondi-
tioning hypoxia (Additional file 1 figure S5).
Since some or many of the changes of gene expres-
s i o nd e s c r i b e dh e r em a yp l a yar o l ei np r o d u c i n g
hypoxia-preconditioning and protecting brain against
subsequent stroke, we examined the hypothesis that
hypoxia may have modulated many of the same genes
as were modulated by ischemic stroke. We therefore
compared the hypoxia-regulated genes reported here to
stroke-regulated genes identified by recent microarray
studies with Affymetrix GeneChip
®.O n es t u d yf r o m
our group examined the adult Sprague-Dawley rat brain
following a permanent middle cerebral artery occlusion
procedure (MCAO) with Affymetrix rat U34A array
[18]. The other study, conducted by Sarabi et al., sur-
veyed the same C57BL/6J adult mice brain following
transient MCAO procedure with the same Affymetrix
mouse MU430_2 array used in our current study [19].
In both studies gene expression was assessed in cerebral
cortex within 24 hours after the stroke. 575 rat tran-
scripts on the rat U34A array (8,799 transcripts
assessed) were regulated at least 1.5 fold in the periin-
farction cortex by acute ischemic stroke, which were
homologous to 1000 transcripts on our mouse
MU430_2 array. Among the 1000 stroke-regulated tran-
scripts, only 12 transcripts were also regulated by
hypoxia according to our current study (Additional file
2 table S5). Sarabi et al. identified 265 transcripts that
changed expression following stroke [19], but only 13 of
these were also regulated by hypoxia in our current
study (Additional file 2 table S5). Therefore, even
though hypoxia changed expression of 503 transcripts
in the mouse cerebral cortex, less than 5% (24 tran-
scripts) were also regulated by ischemia.
Table 2 Candidate transcription factor families responsible for the early transcriptional up-regulation events in the
forebrain at 1 hr after HP.
Name Transcription Factor
Families
GO function annotation P
Value
Representative
members
Preferentially
associated with
CNS
V
$NFKB
Nuclear factor kappa B/c-rel apoptosis, oxidative stress 0.002 Nfkb
V
$CP2F
CP2-erythrocyte Factor
related to drosophila Elf1
steroid biosynthetic process 0.003 Cp2
V
$YBXF
Y-box binding transcription
factors
negative regulation of apoptosis, response to cold 0.003 Csda
V
$CTCF
CTCF and BORIS gene
family transcriptional
regulators
DNA methylation 0.005 Ctcf
V$GLIF GLI zinc finger family CNS development, negative regulation of cell proliferation,
neurogenesis
0.005 Gli1/Gli3 Yes
V
$EBOX
E-box binding factors apoptosis, cell cycle arrest, cell proliferation, ER stress response,
regulation of glycolysis
0.008 Nmyc-1, Myc Ubiquitous
V
$AHRR
AHR-arnt heterodimers and
AHR-related factors
apoptosis, cell cycle, nervous system development, response
to stress
0.010 AHR/ARNT
dimers
V
$AP2F
Activator protein 2 cell-cell signaling, nervous system development 0.010 AP2 Ubiquitous
V
$NOLF
Neuron-specific-olfactory
factor
positive regulation of transcription 0.011 Ebf1 Yes
V
$GKLF
Gut-enriched Krueppel like
binding factor
mesodermal cell fate determination, negative regulation of cell
proliferation
0.029 Klf4
V
$HESF
Vertebrate homologues of
enhancer of split complex
Notch signaling pathway, cell proliferation, circadian clock,
negative regulation of neuron differentiation, vasculogenesis
0.034 Hes1-6 Yes
V
$MZF1
Myeloid zinc finger 1 factors N/A 0.034 Mzf1 Ubiquitous
V
$HIFF
Hypoxia inducible factor,
bHLH/PAS protein family
CNS development, oxygen homeostasis, circadian rhythm,
response to temperature stimulus
0.042 HIF-1a, HIF-2a Ubiquitous
V
$GREF
Glucocorticoid responsive
and related elements
cell growth, cell proliferation, glucocorticoid receptor signaling
pathway
0.047 Nr3c1 Ubiquitous
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Page 6 of 16Unique response of the cerebellum to hypoxia compared
to hippocampus
Not only did cerebellum exhibit the most expression
changes following HP among all brain regions (1312
transcripts in cerebellum vs. 647 transcripts in hippo-
campus with a 1.5-fold threshold), it had the largest
number of up-regulated genes. We therefore explored
the uniqueness of hindbrain structure cerebellum’sg e n e
expression response to HP in comparison with the fore-
brain structure hippocampus because they are compar-
able in many aspects. They each have a particularly
vulnerable cell type: pyramidal cells in hippocampus and
Purkinje cells in cerebellum; structurally they share
similar grey matter and white matter divisions; and both
are relatively primitive brain structures that originated
from the archipallium.
Molecular functions of the hypoxia regulated genes
were explored in each brain region using Ingenuity soft-
ware. Analyses were performed on the genes regulated
at one hour of hypoxia (H1), three hours of hypoxia
(H3) and one hour of re-oxygenation (R1) since the lar-
gest numbers of genes were regulated at these times in
all brain regions (Figure 2). Hypoxia-regulated genes
that differed between cerebellum and hippocampus fell
into two broad categories: cell survival, growth and pro-
liferation (Figure 4A); and cell activities, including cell
morphology, cell movement, cell maintenance, cell to
cell signaling, molecular transport, metabolism and gene
expression, which collectively reflect the overall vibrancy
of the cell (Figure 4B). Similar numbers of genes were
moderately up-regulated in cerebellum and hippocam-
pus in cell survival-related functions or cell activity-
related functions at one hour of hypoxia (Figures 4A, B).
However, after three hours of hypoxia and after one
h o u ro fr e - o x y g e n a t i o nt h e r ew e r em a n ym o r eg e n e s
up-regulated in cerebellum compared to hippocampus
for virtually every cell survival-related functions, and
consistently, cell activity-related functions including
gene expression regulation (Figures 4A, B).
Hypoxia responsive pathways in the cerebellum
The signaling pathways for those genes up-regulated only
in the cerebellum but not in the hippocampus (1241
transcripts with at least 1.2 fold change) were examined
using the Ingenuity Knowledge Base (Table 3 P < 0.1).
Many expected pathways were identified including HIF-
mediated hypoxia signaling, VEGF signaling, the NRF2-
mediated oxidative stress response pathway and others.
Together with the pathway analysis in the forebrain
(Table 1), the results indicate that insulin-like growth fac-
tor 1 (IGF-1), glucocorticoid receptor signaling and the
vitamin D3 receptor/retinoid X receptor (VDR/RXR) sig-
naling play important roles in both the cerebellum and
hippocampus. However, each of these pathways has
engaged different sets of genes in cerebellum compared
to hippocampus and other brain regions. Genes in other
pathways, such as the integrin signaling and protein ubi-
quitination pathways, were exclusively up-regulated only
in cerebellum (data not shown). It is notable that inflam-
mation-related signaling is also represented in these cere-
bellum specific, hypoxia-regulated genes including Fcg
receptor-mediated phagocytosis signaling, interleukin-8
(IL-8) and IL-12 signaling (Table 3).
Hypoxia regulated, cerebellum specific HNF4A target
genes
According to the above pathway analysis, transcription
factors, including glucocorticoid receptor, estrogen
receptor and VDR/RXR, along with HIF played signifi-
cant roles in mediating the cerebellum region-unique
gene expression responses (Table 3), though this did not
explain the entire cerebellum-specific response. To
further address this question, the 1,241 transcripts up-
regulated only in cerebellum with at least 1.2 fold
change were subjected to network analysis in the Inge-
nuity Knowledge Database. Remarkably, the transcrip-
tion factor hepatic nuclear receptor 4A (HNF4A) was
the hub molecule for a large network that exhibited pro-
tein-DNA interactions with the genes corresponding to
186 transcripts up-regulated only in cerebellum but not
in hippocampus (Figure 5). The genes represented by
the 186 transcripts are all verified HNF4A target genes
using ChIP-on-chip (chromatin immunoprecipitation
combined with microarray chip) [20]. The presence of
such a large number of HNF4A target genes in the
given list of cerebellum unique genes was statistically
significant (P = 0.0001, Chi-square test). In contrast,
only 23 HNF4A potential target genes were up-regulated
by hypoxia in both cerebellum and hippocampus.
As the whole cerebellum was used in our current
study, we sought evidence for the cellular localization of
HNF4A using the Allen Mouse Brain Atlas (8-week old
male C57BL/6J mice; in situ hybridization of ~20,000
genes; Allen Institute for Brain Science, Seattle, WA,
http://mouse.brain-map.org). A picture from this atlas
(Figure 5B) shows HNF4A mRNA in most if not all Pur-
kinje cells of the cerebellum and in scattered cells in the
granule cell layers (Figure 5B). HNF4A expression is
almost absent in the molecular layers and in the deep
nuclei of cerebellum (not shown). This restricted expres-
sion in a minority of the cells in cerebellum may explain
the failure to detect HNF4A mRNA in whole cerebellum
using RT-PCR (Mouse Genome Database, The Jackson
Laboratory, Bar Harbor, Maine, http://www.informatics.
jax.org) or on microarrays [21] or in our current study.
HNF4A mRNA in situ hybridization has yet to be done
in hypoxic cerebellum where cellular localization might
change considerably.
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Page 7 of 16Figure 4 Functional comparison of genes regulated by hypoxia in cerebellum versus hippocampu. (A). Comparison of the number of
genes up- or down-regulated by hypoxia that have functions related to cell death/survival in the cerebellum and in the hippocampus. (B).
Comparison of the number of genes up- or down-regulated by hypoxia associated with selected cellular functions in cerebellum and in
hippocampus. The side-by-side comparison between cerebellum and hippocampus was made at three time points: immediately after 1 hr of
hypoxia (H1), immediately after 3 hr of hypoxia (H3), and 1 hr after reoxygenation (R1). Y-axis shows the number of up (dark red bar,) or down
(blue bar) regulated genes associated with each category of molecular functions in each region. Different categories of functions were indexed
to the right of the figure. Biochem.: Biochemistry; Meta.: Metabolism.
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Page 8 of 16Since there has not been any study of potential
HNF4A target genes specifically in the cerebellum, a
promoter site analysis was therefore performed in Geno-
matix software to identify additional potential target
genes of HNF4A. The results show that 54% (642 genes)
of the hypoxia-regulated genes seen only in cerebellum
have HNF4A binding sites in their promoter regions. A
total of 381 of the 642 genes have two or more binding
sites for HNF4A. More interestingly, the integrin signal-
ing pathway, which was exclusively up-regulated in cere-
bellum but not in hippocampus, was the most
significant signaling pathway regulated by the 642
potential HNF4A target genes in the cerebellum.
Discussion
The results demonstrate both time- and region-depen-
dent gene expression responses to hypoxia. Of the 2324
hypoxia-regulated transcripts, most are specifically regu-
lated in just a few brain regions. Some of them are
under the control of similar transcription factors across
regions like HIF-1a,G Ra n dV D R / R X R ,w h i l eo t h e r s
are not. A unique finding is that a large number of
cerebellum-specific hypoxia responsive genes appear to
be uniquely regulated by the HNF4A transcription fac-
tor. The finding of more up-regulated than down-regu-
lated genes in cerebellum and other hindbrain
structures compared to more down-regulated genes in
forebrain, points to possible sacrifice of forebrain cogni-
tive functions for support of life-preserving hindbrain
functions during periods of marked hypoxic stress.
Predominant down-regulation of genes over up-regu-
lation in forebrain following hypoxia could conserve
energy but compromise specific forebrain functions.
However, there are still many up-regulated genes in
forebrain following hypoxia, and these are more
involved in regulation of cell survival and cell growth
than the down-regulated genes. This selective up regula-
tion of cell survival genes, moreover, was a common fea-
ture for all the other investigated brain regions. Specific
pathways included those for HIF signaling, glucocorti-
coid signaling, and P53 signaling, PI3K/AKT and ERK/
MAPK signaling. Though the degree of hypoxia used in
this study does not produce cell death [3,22,23], it may
produce diffuse single strand DNA breaks that require
Table 3 Canonical signaling pathways associated with region-specific up-regulated genes in the cerebellum following
HP.
Pathway No. of
Genes
P Genes
Hypoxia Signaling in the Cardiovascular
System
10 0.0003 UBE2V2, BIRC6, JUN, UBE2G2, UBE2R2 (includes EG:54926), HIF1A, EDN1, PTEN,
UBE2G1, VHL
Integrin Signaling 18 0.0011 ARF6, PIK3CA, CRKL, ITGB5, PXN, FYN, DOCK1, PTK2, RHOU, ITGA6, RHOT1, TSPAN5,
RHOJ, BCAR1, BCAR3, PTEN, RHOV, ZYX
VEGF Signaling 10 0.0021 PRKCB1, EIF1AY, EIF1, FOXO1, EIF2S2, PIK3CA, PXN, HIF1A, FOXO3, PTK2
Fc gammar Receptor-mediated
Phagocytosis in Macrophages and
9 0.0195 PRKCB1, ARF6, PRKCD, PXN, FYN, VAMP3, DGKB, DOCK1, PTEN
Protein Ubiquitination Pathway 14 0.0204 UBE2V2, PSMC6, FBXW7, UBE2R2 (includes EG:54926), CUL2, PSMA1, VHL, USP7,
BIRC6, UBE2G2, TRAF6, USP53, USP2, UBE2G1
IL-8 Signaling 13 0.0269 PRKCB1, PRKCD, GNG4, PIK3CA, GNB2L1, PTK2, ARAF, RHOU, RHOT1, TRAF6, RHOJ,
RHOV, GNA13
14-3-3-mediated Signaling 12 0.0295 ARAF, PRPF4B, PRKCB1, JUN, DYRK1A, CDK7, PRKCD, FOXO1, PIK3CA, PLCD1,
TUBA4A, CSNK1A1
Selenoamino Acid Metabolism 4 0.0302 MAT2A, GGT7, SEPHS2, MARS2
IGF-1 Signaling 8 0.0339 IGFBP1, JUN, FOXO1, PIK3CA, CTGF, PXN, FOXO3, PTK2
Estrogen Receptor Signaling 9 0.0427 TAF11, IGFBP1, CDK7, POLR2D, TAF9, DDX5, TAF5L, PPARGC1A, NCOA2
VDR/RXR Activation 7 0.0457 PRKCB1, IGFBP1, PRKCD, FOXO1, CEBPB, MXD1, NCOA2
NRF2-mediated Oxidative Stress Response 12 0.0525 PRKCB1, JUN, PRKCD, HSPB8, SOD1, PIK3CA, HERPUD1, CUL3, DNAJC5, FKBP5,
DNAJC11, MAF
Tight Junction Signaling 11 0.0617 CTNNA1, EPB41, PPP2CA, CPSF6, JUN, CSTF1, CNKSR3, CSTF3, MYH7B (includes
EG:668940), VAPA, PTEN
IL-12 Signaling and Production in
Macrophages
8 0.0631 JMJD6, PRKCB1, JUN, PRKCD, PIK3CA, TRAF6, CEBPB, MAF
Glucocorticoid Receptor Signaling 15 0.0933 TAF11, AGT, CDK7, SMARCD2, PIK3CA, CEBPB, FKBP5, TAF9, TAF5L, NCOA2, JUN,
NR3C2, POLR2D, TRAF6, GTF2A2
PTEN Signaling 7 0.0955 FOXO1, PIK3CA, CNKSR3, BCAR1, FOXO3, PTEN, PTK2
A total of 1,241 transcripts that were up-regulated at least 1.2-fold in the cerebellum, but not in the hippocampus, were included in the analysis. The Fisher’s
exact test was used to determine the significance of each signaling pathway; significance was defined as a P value less than 0.1.
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Page 9 of 16Figure 5 Central role of transcription factor HNF4A in the region-specific response of cerebellum to hypoxia. (A).N e t w o r kd i a g r a m
showing the interactions between HNF4A and its numerous target genes that were up-regulated by hypoxia at least 1.2-fold in the cerebellum,
but not in the hippocampus. The orange lines indicate interactions between molecules. (B). Baseline expression pattern of HNF4A at the cellular
level in the cerebellum of 8-week old male C57BL/6J mice using in situ hybridization(ISH) (Image ID 1746, Specimen ID 2397, Position 1875 from
Allen Mouse Brain Atlas, Allen Institute for Brain Science, Seattle, WA, http://mouse.brain-map.org, accessed in April 2009). The left panel is the
high power view of HNF4A expression in cerebellum cortex (the framed area in the right panel). The expression level is color coded. The right
panel is the original Allen Mouse Brain Atlas image of the whole cerebellum (coronal section).
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Page 10 of 16repair [24,25]. This may account for the up-regulation of
p53, PI3K/AKT and other pathways involved in DNA
repair [26]
Among the hypoxia regulated genes, many are known
HIF target genes [5,27,28]. Though HIF-1a plays a pivo-
tal role in hypoxia sensing and signal transduction, its
role in mediating hypoxia induced preconditioning effect
is controversial, with several studies suggesting that
HIF-1a might promote ischemic injury [29-32]. Micro-
array studies with brain specific HIF-1a knock out
mouse even show that HIF-1a is dispensable for the
hypoxia response[31]. If HIF related responses do not
account for hypoxia preconditioning, then there must be
other transcription factors and genes. Indeed, over half
of the hypoxia regulated genes common to all brain
r e g i o n sl a c kH I Fb i n d i n gs i t e si nt h e i rp r o m o t e r sb u t
have sites for other hypoxia responsive transcription
factors.
The glucocorticoid transcription regulation pathways
are not commonly thought of as being associated with
hypoxia and other types of preconditioning. However,
these pathways might be considered since our promoter
analyses show that genes with GRE (Glucocorticoid
Responsive Elements) in their promoters are over-repre-
sented in those induced by one hour of hypoxia(Table
2), which is sufficient to produce hypoxia precondition-
ing [8]. Glucocorticoids are systemic stress hormones
and can activate the glucocorticoid receptor (GR), a
transcription factor that acts on GRE promoter elements
[33]. Although the role of glucocorticoids in the context
of HP has not been addressed, it is known that hypoxia
(8% oxygen) increases glucocorticoids in the blood
within 30-60 minutes [34-36]. Glucocorticoids can aug-
ment the expression of HIF1a-dependent genes via a
direct interaction with HIF-1a [37]. Administration of
synthetic glucocorticoids can decrease high altitude sick-
n e s s ,i . e .b r a i ne d e m ad u et oh y p o x i a[ 3 8 ] .G l u c o c o r t i -
coids applied 20 hours in advance can protect rat
neurons from excitotoxin-induced apoptosis through
PI3K/Akt-dependent phosphorylation of Cdkn1a [39].
Of note, our data show that hypoxia increased the
expression of Cdkn1a (Fig. S2). According to our data,
hypoxia induces many other glucocorticoid-inducible
genes, including Tsc22d3, Sgk1,a n dNfkb1a,a sw e l la sa
member of the GR complex - FKBP5 (FK506 binding
protein 5). Thus, glucocorticoid signaling could produce
an alarm response to the hypoxia stress to augment the
adaptive genomic response. Whether GR signaling plays
a role in preconditioning has yet to be tested.
T h e r ei sp r o b a b l yn o tas i n g l ep r o - s u r v i v a lm o l e c u l e
or one pro-survival signaling pathway that accounts for
hypoxia preconditioning. The redundant activation of
multiple pro-survival mechanisms has been observed in
many models, including hypoxia and ischemic
preconditioning models [9,17,40]. Cellular protection
may occur at many levels - and thus multiple pathways
are needed to protect the cells as shown in Table 1.
The hypoxia preconditioning response appears to have
little in common with an injury response. For example,
very few transcripts were regulated by both hypoxia and
ischemic stroke in the cerebral cortex (Additional file 2
table S5). A similar result has been found between an
ischemic preconditioning and an ischemic stroke-
induced gene expression response [17]. This result indi-
cates that the protective effect induced by hypoxia is not
achieved through a simple rehearsal of the ischemia
event, but through a reprogramming of the transcrip-
tional response [17].
Unlike the forebrain, there were many more up-regu-
lated than down-regulated genes in cerebellum and
other hindbrain structures including the pons and
medulla. This could be due to the fact that brainstem
and cerebellum play critical roles in maintaining cardiac
and respiratory functions during periods of severe
hypoxia and that higher order cognitive functions are
shut down to conserve energy stores during hypoxia
[41-43]. Indeed, hypoxic mice and other mammals are
lethargic and inactive, but have marked increases of
respiration, heart rate and autonomic responses during
hypoxia. Our findings on the regional differences serve
to emphasize that some aspects of “hypoxia precondi-
tioning” in vivo may not be recapitulated by hypoxia or
ischemia preconditioning in vitro.
The large number of up-regulated genes in cerebellum
following hypoxia could suggest an important central
role for cerebellum in the brain’s preconditioning
response. As noted above, cerebellum may play a role in
coordinating respiratory, circulatory and other auto-
nomic responses to hypoxia[41,42]. Though possible, it
is not clear why there would not be similar numbers of
up-regulated genes in the pons and medulla where these
functions are primarily controlled. An alternative role
for cerebellum in hypoxia preconditioning might occur
through “central neurogenic neuroprotection,” which is
produced by stimulation of the cerebellum fastigial
nucleus (FN) [44]. Reis and coworkers found that one
hour of electrical stimulation of the FN prior to injury
protected the rat brain from subsequent focal ischemia
1-3 days later [45,46]. The time course of this central
neurogenic neuroprotection is similar to that of hypoxia
preconditioning. The mechanism of neuroprotection is
unknown, though FN stimulation pretreatment can
decrease inflammation following ischemia and can mod-
ify the intrinsic sensitivity of forebrain neurons to apop-
totic stimuli [47,48]. The many up-regulated genes in
cerebellum produced by hypoxia imply that the cerebel-
lum was indeed “stimulated.” It is tempting to speculate
that changes of gene expression in cerebellum during
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Page 11 of 16the hypoxia may be responsible, at least in part, for the
hypoxia-induced neuroprotective effect through the
“central neurogenic protection” mechanism. Indeed, an
excitotoxic lesion of FN neurons prior to precondition-
ing ischemia blocks the neuroprotective effect of
ischemic preconditioning against global ischemia in the
rat [49]. Even though the cerebellar FN-mediated neuro-
protection effect has been well documented, the neuro-
nal circuitry from cerebellum to forebrain responsible
for the preconditioning still has not been identified.
Although the cerebellum exhibits a different response
to hypoxia compared to the hippocampus, the response
in the cerebellum is still mediated to an extent by well-
known hypoxia responsive signaling pathways. Besides
HIF-1a, a series of nuclear receptor transcription factors
appear to have important roles in the cerebellum-speci-
fic up regulation response, including GR, NRF2 (NF-E2-
related factor 2), VDR/RXR, and estrogen receptor. One
of the major findings of this study, however, is that over
half of the 1241 hypoxia-regulated genes unique to cere-
bellum have binding sites in their promoters for
HNF4A, another member of the nuclear receptor family.
As a tissue-specific transcription factor, hepatocyte
nuclear factor 4A (HNF4A) was originally identified as a
key transcription factor responsible for expression of
hepatic-specific genes and is involved in tissue-specific
cell differentiation and energy metabolism [20,50].
Mutations in this gene have been associated with mono-
genic autosomal dominant non-insulin-dependent dia-
betes mellitus type I, which stresses the important role
of HNF4A in energy metabolism [51]. In addition, con-
ditional HNF4A-knockout mice have down-regulation of
a series of cell adhesion and junction molecules and
severe failure of epithelial transformation [52], which is
consistent with the potential HNF4A target genes regu-
lated in the hypoxic cerebellum.
HNF4A is also known to be involved in the hypoxia
response. HNF4A can interact directly with both HIF-
1a and HIF-1b and is required for erythropoietin (EPO)
transcription during hypoxia through interaction with
HNF4A binding element in the EPO enhancer in the
liver and kidney [53]. Mutation of the HNF4A binding
site in the EPO promoter abolishes hypoxic induction of
EPO [54]. According to our data, HNF4A appears to
activate transcription for a large number of cerebellum-
specific hypoxia responsive genes. Though a role for
HNF4A in the hypoxia response in brain has yet to be
proven, the current findings suggest that it plays a
major role in the transcriptional response to hypoxia in
the mammalian cerebellum.
Conclusions
To the best of our knowledge, our data uncovered so far
the most complete HP-induced gene expression
responses in the adult mouse brain. Our results confirm
that HP elicits both time- and region-dependent tran-
scriptional responses that are required for maturation of
the delayed protection effect of HP. Both region-inde-
pendent and region-dependent expression changes were
observed. Developmentally closely related regions share
more commonality than remotely related regions:
roughly, the response in the forebrain regions is distinc-
tive from that in the hindbrain regions. At the same
time, from the whole brain view the region-dependent
response in vivo appears to be a well coordinated one
under limited energy sources, with hindbrain function
being well supported somewhat at the expenses of the
forebrain function. Nonetheless, selective up-regulation
of cell survival related genes appears to be a common
feature for all the brain regions including the forebrain.
A large proportion of HP-regulated genes themselves
are gene expression regulato r s .T h ed a t aa n a l y s i ss u g -
gested the complexity of such underlying transcriptional
regulation mechanism: both universal transcriptional
regulation mechanism, such as HIF and GR, and region-
specific transcription factors, such as HNF4A, have been
responsible for the region-specific gene expression
changes which is related to cell survival. It is likely that
a cascade of signaling pathways rather than any single
pathway has mediated the HP response and protection
mechanism. Our data also revealed novel transcriptional
regulation mechanisms that may have been underappre-
ciated in HP neuroprotection mechanism, and indicated
the potentially important role of cerebellum and other
hindbrain structures in HP. The exact mechanism and
function of the region-dependent responses to HP
remain to be fully elucidated.
Methods
Animals
All studies were reviewed and approved by IACUC
(Institutional Animal Care and Use) committee of the
University of California at Davis. All mice had food and
water available ad libitum on a 12 hour light/dark cycle,
and were acclimated to the animal room for at least one
week before the experiment.
Hypoxia and Tissue Samples
C57BL/6 male mice, ages 8-9 weeks, were exposed to
8% O2 and 92% N2 for 3 hours in hypoxia chambers
(BioSpherix, NY, USA) and then returned to room air in
their home cages for 24 hours. Sham-treated control
mice were also placed in the same chambers but with
room air for 3h, and then returned to their home cages
for 24h. During the experiments mouse brains were
removed and dissected in a cold room (4°C) at the fol-
lowing time points: immediately after 1 hr of hypoxia
(H1), immediately after 3 hr of hypoxia (H3), and after
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Page 12 of 161 (R1), 3 (R3), 6 (R6), 12 (R12), and 24 (R24) hours of
re-oxygenation (R). Total RNA was purified from the
following brain regions: cerebral cortex, hippocampus,
striatum, thalamus, midbrain, cerebellum and pons/
medulla. Three mice were studied for each hypoxia time
point and sham condition, for a total of 24 mice studied
and 168 samples (microarrays).
RNA and microarray
Brain samples were homogenized in 1 ml of TRIZOL
Reagent (Invitrogen Corporation, Carlsbad, California).
RNA purification was carried out according to the man-
ufacturer’s recommendations (Protocol 18057N, Invitro-
gen Corporation, Carlsbad, CA). The RNA pellet was
cleaned using a RNAeasy mini kit (Qiagen, Valencia,
CA). RNA purity and integrity were assessed using a
Nanodrop spectrophotometer (NanoDrop Technologies,
Wilmington, DE) and an Agilent Bioanalyzer (Agilent
Technologies Inc., Palo Alto, CA). Samples (5 μgo f
total RNA) were processed on whole genome “Gene-
Chip
® Mouse Expression 430 2.0” arrays according to
the Affymetrix technical manual (Affymetrix GeneChip
®
Expression Analysis Manual 701023, Rev. 4, Affymetrix).
Samples had to have an A260/A280 absorbance ratio
greater than 1.9 and a 28S/18S rRNA ratio greater than
1.5. The raw data are available through NCBI Gene
Expression Omnibus (GEO) with series accession num-
ber [GEO: GSE19709].
Microarray Data Analysis
Raw signals were transformed into .CEL files in GCOS
software (Affymetrix, Santa Clara, CA). Probe data were
generated using the Robust Multi-chip Average with
GC-content Background Correction (GCRMA, http://
www.bioconductor.org) in Genespring 7 software (Sili-
con Genetics, Redwood City, CA). This involves back-
ground correction, quantile normalization, and
summarization of the probe-set values into gene-level
expression measurements. The expression data for each
brain region of hypoxia treated mice were then normal-
ized to the averaged values for each brain region from
the sham treated mice. Differentially regulated genes
were determined using a one-way ANOVA analysis and
a Benjamini Hochberg False Discovery Rate (FDR)
(<0.05) method for multiple comparison corrections
[55], followed by a Student’s post hoc test.
We performed a separate analysis that was designed to
minimize the number of false negative genes. Those
genes whose expression changed little under the differ-
ent experimental conditions were filtered out. Specifi-
cally, only those genes whose expression changed at
least 1.3-fold from the baseline value in at least two of
the hypoxia-treated samples were selected for down-
stream analysis. This filter helped maximize the number
of genes. This approach removed approximately 60% of
probe sets prior to further analysis. The remaining
genes were then subjected to a one-way ANOVA analy-
sis. The resulting gene lists not only contained a signifi-
cant number of genes that overlapped with the one
generated by the aforementioned analysis with no pre-
filtering, but it also contained a significant number of
genes missed in the initial analysis without the pre-fil-
tering step. These additional positive genes were then
combined with the genes derived from the initial analy-
sis without pre-filtering. Less stringent 1.2 fold change
gene lists were used for functional analyses and more
stringent 1.5-fold change gene lists were used to analyze
transcription factor binding sites.
For example, in the cerebral cortex, the analysis of HP
samples using pre-filtering indicated that the expression
of 831 genes changed during the time course; this set of
genes included 94.4% of the 531 genes generated by the
same analysis without pre-filtering. The additional 339
genes in the pre-filtering analysis were added to the
initial 531 genes, resulting in the final list of 860 genes.
However, if a 1.5 fold change cut off was used, a total of
503 genes were identified as HP regulated genes in the
cerebral cortex.
Functional Analysis
Genes that met statistical criteria were analyzed using
Ingenuity Pathways Analysis (IPA 6.5, Ingenuity
® Sys-
tems, http://www.ingenuity.com) to explore molecular
functions, signaling pathways and interaction networks.
These analyses identified the most statistically significant
biological functions or canonical pathways in the data
set. Fischer’s exact test was used to calculate a p-value
describing the probability that a given biological func-
tion or canonical pathway was assigned to that data set
due to chance alone. An interaction network is a graphi-
cal representation of the molecular relationships
between genes and gene products. Gene products are
represented as nodes, and the biological relationship
b e t w e e nt w on o d e si sr e p r e s e n t e da sal i n et h a ti ss u p -
ported by at least one reference from the literature.
The in situ hybridization data for HNF4A mRNA
expression in cerebellum were obtained from the Allen
Brain Atlas, a genome-wide image database of gene
expression in the brain of8w e e ko l dC 5 7 B L / 6 Jm i c e
(http://mouse.brain-map.org). Non-radioactive digoxi-
genin-labeled HNF4A riboprobes were synthesized and
hybridized to HNF4A mRNA in brain tissue sections.
Detailed methods can be found in the reference for the
Allen Brain Atlas [56].
Promoter Prediction and Analysis
Transcription factor binding site (TFBS) analysis of the
promoter sequences was carried out in GEMS Software
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genome annotation, promoter sequence retrieval, a search
engine for transcription factor binding sites, and a tran-
scription factor knowledge base. Promoter sequences were
extracted from 500 bp upstream and 100 bp downstream
of the transcription start site of genes of interest. Although
the exact length of a promoter can only be defined experi-
mentally, a commonly accepted definition of proximal
promoter region for transcription factor binding is typi-
cally 250-500 bp located directly upstream of the site of
initiation of transcription in eukaryotes [57]. It is a com-
mon practice for an initial in silico analysis to refrain from
extending the length beyond the proximal promoter
region. This will help to minimize false positive findings
for computation prediction. Genomatix develops opti-
mized algorithm for promoter modeling and predicting
based on the region between 500 bp upstream and 100 bp
downstream of the transcription start site. MatInspector
within GEMS was used to scan transcription factor matrix
matches in input sequences based on position weight
matrices. The weight matrix for a specific transcription
factor binding site reflects the differences in the degree of
conservation of a specific nucleotide at a specific position.
In order to reduce false positives, the resulting matrix
similarity score for a transcription factor was compared to
the optimized threshold value which is individualized for
individual transcription factor binding site matrix [58]. A
p value was then determined as the probability to obtain
an equal or greater number of sequences with a match in
a randomly drawn sequence set of the same size as the
input sequence set. The computational methods used in
Genomatix have been successfully applied to identify pro-
ven functional transcription factor binding sites [59,60].
Additional data files
The following additional data files are available with the
online version of this paper: Additional file 1 contains
Figure S1 to S5; Additional file 2 contains Table S1 to
S5.
Additional material
Additional file 1: Figure S1. Classification overview of the hypoxia-
regulated genes in the brain. (A). Sub-cellular localization of proteins
encoded by these genes. (B). Molecular type classifications of the gene
products. Figure S2. Time course of expression of selected HIF-1 alpha
target genes in all brain regions studied. Diagram of the expression
activities of Cdkn1a (Cyclin-dependent kinase inhibitor 1A (P21)) and
Ddit4 (DNA damage-inducible transcript) over the time course after HP
treatment in each brain region. Figure S3. Cluster analysis diagram of the
expression profiles from each forebrain region. Expression heatmap and
cluster tree diagram showing the common expression pattern of the 300
transcripts over the time course after HP treatment in all three forebrain
regions. Figure S4. Interactive signaling network associated with the
genes up-regulated by HP in all the forebrain regions. Diagram of the
interplay among various signaling pathways during the responses to HP
treatment. Figure S5. Expression of krueppel-like binding factor 4 (Klf4)i n
the forebrain regions after HP. Shows the expression changes of Klf4
genes, represented by two probes, in each forebrain region over the
time course after preconditioning hypoxia.
Additional file 2: Table S1. Verified HIF-1 alpha target genes
regulated by HP. List of verified 17 HIF-1 alpha target genes which are
regulated by HP in at least one of the brain regions investigated. Table
S2. Computationally predicted HIF-1alpha target genes whose expression
was regulated by HP. List of 38 predicted HIF-1alpha target genes which
are regulated by HP in all brain regions. Table S3. Molecular functions
significantly associated with the top three networks formed by HP-
regulated genes in each forebrain region. The top networks were ranked
by their significance scores determined by network analysis in Ingenuity
database. Table S4. Transcripts commonly up-regulated in all the three
forebrain regions. List of 87 transcripts commonly up-regulated in
cerebral cortex, hippocampus and striatum. The time points at which the
transcript showed statistically significant expression change are provided
together with corresponding fold change value. Table S5. Common
genes regulated by both hypoxia preconditioning and acute ischemia in
the brain. List of genes commonly regulated in both mice HP model and
rodent (mice or rat) MCAO model.
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